Sonidegib
Showing 1 - 23 of 23
Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)
Recruiting
- Locally Advanced Basal Cell Carcinoma
- Sonidegib
-
Brescia, ItalyAsst Degli Spedali Civili Di Brescia
Aug 3, 2022
Basal Cell Carcinoma, Basal Cell Carcinoma of Skin, Site Unspecified, Skin Cancer Trial in North Sydney (drug, procedure, other)
Recruiting
- Basal Cell Carcinoma
- +3 more
- Sonidegib
- +3 more
-
North Sydney, New South Wales, AustraliaMelanoma Institute Australia
Jun 9, 2022
Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,
Recruiting
- Basal Cell Carcinoma
- +10 more
- Vismodegib
- Sonidegib
-
Nijmegen, Gelderland, Netherlands
- +7 more
Jul 14, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Laboratory Biomarker Analysis, Lenalidomide,
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Dec 1, 2021
Basal Cell Carcinoma Trial in Zürich (Cemiplimab Injection [Libtayo])
Recruiting
- Basal Cell Carcinoma
- Cemiplimab Injection [Libtayo]
-
Zürich, SwitzerlandUniversity Hospital Zurich, Clinic of Dermatology
Nov 3, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +38 more
- Pembrolizumab
- Sonidegib
-
Scottsdale, Arizona
- +2 more
Aug 27, 2021
Pancreatic Ductal Adenocarcinoma Trial in Baltimore (LDE225-600mg, Gemcitabine, nab-paclitaxel)
Terminated
- Pancreatic Ductal Adenocarcinoma
- LDE225-600mg
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 17, 2020
Medulloblastoma Trial in Zürich (Sonidegib, Cisplatin, Lomustine)
Not yet recruiting
- Medulloblastoma
- Sonidegib
- +4 more
-
Zürich, SwitzerlandUniversity Hospital zurich
May 20, 2020
Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)
Not yet recruiting
- Basal Cell Carcinoma
- Radiotherapy; Complications
- Radiotherapy
- +2 more
- (no location specified)
Sep 30, 2022
Carcinoma, Basal Cell, Recurrent Skin Cancer, Skin Tumors Trial in Stanford (Buparlisib, Sonidegib)
Terminated
- Carcinoma, Basal Cell
- +3 more
- Buparlisib
- Sonidegib
-
Stanford, CaliforniaStanford University School of Medicine
Jan 10, 2019
Prostate Cancer Trial in Baltimore (LDE225)
Completed
- Prostate Cancer
-
Baltimore, MarylandJohns Hopkins Hospital
Nov 13, 2018
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
Basal Cell Carcinoma Trial in Stanford (LDE225)
Completed
- Basal Cell Carcinoma
-
Stanford, CaliforniaStanford University, School of Medicine
Nov 23, 2016
PTCH1 or SMO Activated Solid and Hematologic Tumors Trial in United States (LDE225)
Terminated
- PTCH1 or SMO Activated Solid and Hematologic Tumors
-
Sacramento, California
- +9 more
Apr 25, 2016